GSK and UK researchers plan to study Shingrix and dementia risk reduction link
The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
Neurology
Tempero secures $70m to advance addiction treatment candidate
Augustine secures $85m to advance Charcot-Marie-Tooth candidate
SmartCella gains rights to advance cell therapy research for Parkinson’s
Supernus wins FDA approval for Parkinson’s pump on fourth try
Eisai and Biogen’s subcutaneous Leqembi set for FDA review
Neumora shares sink following Phase III flop in MDD
Astellas and Sangamo sign capsid deal for neurological diseases
